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 ABSTRACT 
 Coagulase-negative staphylococci (CNS; n = 417) 
were isolated from bovine milk and identified by 
matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry. Nineteen different species 
were identified, and Staphylococcus xylosus, Staphylo-
coccus chromogenes, Staphylococcus haemolyticus, and 
Staphylococcus sciuri were the most prevalent species. 
Resistance to oxacillin (47.0% of the isolates), fusidic 
acid (33.8%), tiamulin (31.9%), penicillin (23.3%), 
tetracycline (15.8%), streptomycin (9.6%), erythromy-
cin (7.0%), sulfonamides (5%), trimethoprim (4.3%), 
clindamycin (3.4%), kanamycin (2.4%), and gentamicin 
(2.4%) was detected. Resistance to oxacillin was attrib-
uted to the mecA gene in 9.7% of the oxacillin-resistant 
isolates. The remaining oxacillin-resistant CNS did not 
contain the mecC gene or mecA1 promoter mutations. 
The mecA gene was detected in Staphylococcus fleuret-
tii, Staphylococcus epidermidis, Staph. haemolyticus, 
and Staph. xylosus. Resistance to tetracycline was at-
tributed to the presence of tet(K) and tet(L), penicil-
lin resistance to blaZ, streptomycin resistance to str 
and ant(6)-Ia, and erythromycin resistance to erm(C), 
erm(B), and msr. Resistance to tiamulin and fusidic 
acid could not be attributed to an acquired resistance 
gene. In total, 15.1% of the CNS isolates were multi-
drug resistant (i.e., resistant to 2 or more antimicrobi-
als). The remaining CNS isolates were susceptible to 
antimicrobials commonly used in mastitis treatment. 
Methicillin-resistant CNS isolates were diverse, as de-
termined by mecA gene sequence analysis, staphylococ-
cal cassette chromosome mec typing, and pulsed-field 
gel electrophoresis. Arginine catabolic mobile element 
types 1 and 3 were detected in both methicillin-resis-
tant and methicillin-susceptible Staph. epidermidis and 
were associated with sequence types ST59 and ST111. 
Because this study revealed the presence of multidrug-
resistant CNS in a heterogeneous CNS population, we 
recommend antibiogram analysis of CNS in persistent 
infections before treatment with antimicrobials. 
 Key words:  methicillin-resistance , coagulase-negative 
staphylococci , genotyping , antibiotic resistance 
 INTRODUCTION 
 Coagulase-negative staphylococci are the microor-
ganisms most commonly isolated from bovine milk in 
many countries, and they are an important cause of 
mastitis (Pyörälä and Taponen, 2009; Rajala-Schultz 
et al., 2009; Piessens et al., 2011; De Vliegher et al., 
2012). The CNS are opportunistic pathogens that are 
usually diagnosed as a group without species identi-
fication. They cause subclinical IMI that result in an 
increase in SCC and reduced milk quality, leading to 
economic losses (Pyörälä and Taponen, 2009). Because 
simple subclinical CNS infections can be self-limiting, 
they are usually not treated with antibiotics. However, 
CNS often appear with other major pathogens such 
as Staphylococcus aureus, Streptococcus spp., or coli-
form bacteria. In these cases and in persistent CNS 
infections, the cows undergo antimicrobial treatment. 
Currently, β-lactam antimicrobials (including penicillin 
and cephalosporins), aminoglycosides (gentamicin and 
neomycin), and macrolides (spiramycin) are commonly 
used to treat mastitis in Switzerland (Büttner et al., 
2011). Resistance to these antibiotics has been increas-
ingly reported in CNS associated with bovine masti-
tis (Walther and Perreten, 2007; Sawant et al., 2009; 
Sampimon et al., 2011). The CNS may also harbor 
antimicrobial resistance elements and pathogenicity is-
lands, such as the staphylococcal cassette chromosome 
(SCCmec) element (Wielders et al., 2001; Barbier et 
al., 2010; Tsubakishita et al., 2010) and the arginine 
catabolic mobile element (ACME; Diep et al., 2006, 
2008; Miragaia et al., 2009) that can be transferred to 
Staph. aureus. Arginine catabolic mobile elements are 
genomic islands in Staph. epidermidis that are associ-
ated with host colonization, fitness, and pathogenic-
ity. Mobility of ACME is associated with recombinase 
genes present on the SCCmec elements (Goering et al., 
2007; Diep et al., 2008). The SCCmec elements contain 
the mec genes—mecA or mecC (mecALGA251)—which 
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encode alternative penicillin-binding proteins (PBP 
2a) and confer resistance to all β-lactam antimicrobials 
(García-Álvarez et al., 2011; Ito et al., 2012). In Staph. 
sciuri, the mecA gene homolog mecA1 is a native gene 
that is not part of the mec gene complex (Couto et 
al., 1996, 2000; Wu et al., 1998, 2001; Tsubakishita et 
al., 2010). Most Staph. sciuri isolates are susceptible 
to β-lactam antimicrobials. However, alterations in the 
promoter regions of mecA1 upregulate mecA1 expres-
sion and confer methicillin resistance (Wu et al., 2001, 
2005; Couto et al., 2003). Methicillin-resistant staphy-
lococci are often also resistant to other classes of drugs 
such as aminoglycosides and macrolides (Woodford 
2005). Nevertheless, little is known about the molecu-
lar mechanisms of antimicrobial resistance (Lüthje and 
Schwarz, 2006) or the genetic background of multidrug-
resistant CNS strains in bovine milk.
We identified different CNS species in milk from cows 
with clinical and subclinical bovine mastitis, charac-
terized their antimicrobial resistance mechanisms, and 
determined whether specific methicillin-resistant and 
multidrug-resistant CNS clones are common in dairy 
cows.
MATERIALS AND METHODS
Origin of Milk Samples
Coagulase-negative staphylococci (n = 417) were 
isolated from milk (n = 370) obtained from cows diag-
nosed with clinical (n = 115) and subclinical (n = 255) 
mastitis and control samples (n = 47) in Switzerland. 
Control samples were collected from cows that had suf-
fered from mastitis previously and had been treated; 
the control milk samples contained <150,000 cells/mL. 
The 417 isolates came from 363 different cows and from 
2 different mammary quarters of 7 cows. The 363 cows 
originated from 195 different farms (nf) in the cantons 
of Berne (nf = 91), Jura (nf = 56), Fribourg (nf = 
26), Vaud (nf = 8), Lucerne (nf = 5), Valais (nf = 4), 
Solothurn (nf = 3), Aargau (nf = 1), and Thurgau (nf 
= 1). In 47 cases, 2 different CNS strains were found in 
the same milk sample.
Isolation and Identification of CNS
Milk samples were centrifuged at 590 × g for 10 min 
at room temperature. The milk pellets were cultivated 
on tryptone soy agar containing 5% defibrinated sheep 
blood (Becton, Dickinson and Co., Franklin Lakes, 
NJ) and incubated at 37°C for 18 to 24 h. Staphylo-
cocci were selected based on colony morphology, gram-
positive staining of cocci, and catalase production and 
were subcultured on tryptone soy agar containing 5% 
defibrinated sheep blood.
The isolates were identified by matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) analysis using the ethanol–formic 
acid extraction method for better resolution (Micro-
flex LT, Bruker Daltonics GmbH, Bremen, Germany; 
Application Note MT-80, Bruker Daltonics GmbH). 
Species identification was considered valid when the 
matching score with reference spectra of the MALDI 
Biotyper v3.0 database (Bruker Daltonics GmbH) was 
≥2, according to the criteria proposed by the manufac-
turer. Isolates whose measured spectra had score <2.0 
were further identified by DNA sequencing of the 16S 
rDNA (Kuhnert et al., 1996). The CNS strains were 
stored at −80°C in trypticase soy medium containing 
30% glycerin (Becton, Dickinson and Co.).
DNA Extraction and Amplification
To obtain total DNA, cells were incubated in 100 
μL of Tris-EDTA buffer containing 0.1 mg/mL lyso-
staphin for 15 min at 37°C; then, 450 μL of lysis buffer 
(0.1 M Tris-HCl, pH 8.5, 0.05% Tween 20, 0.24 mg/
mL proteinase K) was added and incubated at 60°C 
for 45 min. The DNA was then denatured at 95°C for 
15 min. The PCR was performed with HOT FIREPol 
DNA Polymerase (Solis BioDyne, Tartu, Estonia) using 
the primers and conditions listed in Table 1.
Antimicrobial Resistance Tests
The CNS isolates were tested for antimicrobial suscep-
tibility with the broth microdilution technique (Clinical 
and Laboratory Standards Institute, 2009) using Sen-
sititre susceptibility plates (NLEUST plates; Trek Di-
agnostics Systems, East Grinstead, UK) that contained 
the following 19 antimicrobials: chloramphenicol, cipro-
floxacin, clindamycin, dalfopristin-quinupristin, eryth-
romycin, fusidic acid, gentamicin, kanamycin, linezolid, 
mupirocin, oxacillin, penicillin, rifampicin, strepto-
mycin, sulfamethoxazole, tetracycline, tiamulin, trim-
ethoprim, and vancomycin. The resistance breakpoints 
were those proposed for CNS in the guidelines of the 
European Committee on Antimicrobial Susceptibility 
Testing (EUCAST, www.eucast.org; Table 2), except 
for streptomycin and kanamycin, for which breakpoints 
came from the French Society for Microbiology (www.
sfm-microbiologie.org). The production of β-lactamase 
was tested on nitrocefin dry slides (Becton, Dickinson 
and Co.) using colonies grown on Mueller Hinton agar 
for 18 h at 37°C with 0.05 μg/mL penicillin to induce 
β-lactamase production (Schnellmann et al., 2006). The 
Journal of Dairy Science Vol. 96 No. 4, 2013
ANTIMICROBIAL RESISTANCE IN COAGULASE-NEGATIVE STAPHYLOCOCCI 2249
antimicrobial resistance genes were detected by using 
a custom-made microarray (AMR+ve-2 array tubes, 
Alere Technologies GmbH, Jena, Germany; Perreten et 
al., 2005). The microarray results were analyzed using 
the IconoClust program (Alere Technologies GmbH), 
and the data were interpreted visually.
Characterization of the mec Genes  
and SCCmec Elements
All isolates displaying a MIC for oxacillin above the 
resistance breakpoint (MIC >0.25 μg/mL), which sug-
gests the presence of an alternative penicillin-binding 
protein (based on Clinical and Laboratory Standards 
Institute and EUCAST), were additionally tested by 
PCR for the mecA, mecA1, and mecC genes (García-
Álvarez et al., 2011; Ito et al., 2012) using the primers 
listed in Table 1. The complete nucleotide sequences of 
the mecA genes were obtained by PCR amplification 
with the mecA-F7 and mecA-R7 primers (Table 1). Se-
quencing was performed on an ABI Prism 3100 genetic 
analyzer (Applied Biosystems, Foster City, CA). The 
SCCmec types were determined by the Kondo method 
(Kondo et al., 2007).
Table 1. Primers and primer sequences used in the study 
Target gene Primer name (F = forward; R = reverse) and sequence
Size of PCR  
fragment (bp)
Annealing  
emperature (°C)
mecA, mecA1, mecA2 mecAuniv-F 5c-AAAAGATAAATCTTGGGGTG 525 51
mecAuniv-R 5c-CCTTGTTTCATYTTGAGTTC
mecA mecA-1 5c-AAAATCGATGGTAAAGGTTGGC 533 54
mecA-2 5c-AGTTCTGCAGTACCGGATTTGC
mecA1 mecA1-sc-F 5c-ATTAATCATCGCCATCGTGA 663 52
mecA1-sc-R 5c-TTTGTATCTTGATTCATATTTTGAACA
mecC mecC-F 5c-CAGCCAGATTCATTTGTACC 486 54
mecC-R 5c-AACATCGTACGATGGGGTAC
mecA1 promoter mecAscK1-F 5c-CATATATATATTTATACGCTCATC 335 50
mecAsc-R 5c-TTCAATGGCATCAATTGTTTC
mecA1 
(full-length gene)
mecA-F7 5c-GATAACACCTGCTACAC 2,194 51
mecA-R7 5c-AAGGGAGAAGTAACAGC
1Primers annealing external to mecA for amplification and sequencing of the full-length gene.
Table 2. Distribution of antimicrobial resistance phenotypes in CNS 
Antimicrobial substance
Breakpoint 
(μg/mL)
Resistance phenotype
Total  
(ntotal = 417)
Clinical mastitis 
(ntotal = 115)
Subclinical  
mastitis 
(ntotal = 255)
Control milk 
(ntotal = 47)
No. % No. % No. % No. %
Oxacillin R >0.25 196 47.0 65a 56.5 112a 43.9 19 40.4
Fusidic acid R >1.0 141 33.8 44 38.3 81 31.8 16 34.0
Tiamulin R >2.0 133 31.9 34 29.6 85 33.3 14 29.8
Penicillin R >0.125 97 23.3 26 22.6 63 24.7 8 17.0
Tetracycline R >2.0 66 15.8 18 15.7 37 14.5 11 23.4
Streptomycin R >16 40 9.6 9 7.8 29 11.4 2 4.3
Erythromycin R >2.0 29 7.0 7 6.1 18 7.1 4 8.5
Sulfamethoxazole R >128 21 5.0 13b 11.3 8 3.1 0b 0.0
Trimethoprim R >4.0 18 4.3 6 5.2 11 4.3 1 2.1
Clindamycin R >0.5 14 3.4 3 2.6 10 3.9 1 2.1
Chloramphenicol R >8.0 13 3.1 4 3.5 8 3.1 1 2.1
Gentamicin R >1.0 10 2.4 5 4.4 5 2.0 0 0.0
Kanamycin R >16.0 10 2.4 5 4.4 5 2.0 0 0.0
Quinupristin-dalfopristin R >2.0 0 0.0 0 0.0 0 0.0 0 0.0
Rifampicin R >0.5 0 0.0 0 0.0 0 0.0 0 0.0
Ciprofloxacin R >1.0 0 0.0 0 0.0 0 0.0 0 0.0
Mupirocin R >256 0 0.0 0 0.0 0 0.0 0 0.0
aDenotes a significant difference (P = 0.03) in the number of oxacillin-resistant isolates from clinical and subclinical mastitis cases, as determined 
by Fisher’s exact test.
bDenotes a significant difference (P = 0.02) in the number of sulfamethoxazole-resistant isolates from clinical mastitis cases and control milk, 
as determined by Fisher’s exact test.
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Analysis of the mecA1 Promoter  
Region in Staph. sciuri 
Staphylococcus sciuri isolates carrying a mecA1 homo-
log (n = 37) were analyzed for a point mutation (Wu et 
al., 2001) in the promoter region by restriction analysis 
of PCR products amplified with primers mecAscK1-
F and mecAsc-R (Table 1). The 335-bp PCR product 
was tested for PsiI cleavage using the manufacturer’s 
suggested conditions (New England BioLabs, Beverly, 
MA); PsiI recognizes the mutated promoter sequence 
TATAAT but not the wild-type sequence TATATT.
Genotyping of Methicillin-Resistant CNS
Methicillin-resistant, mecA-positive CNS isolates and 
multidrug-resistant, mecA-negative Staph. epidermidis 
isolates were genotyped by pulsed-field gel electropho-
resis (PFGE). Analysis of SmaI-digested chromosomal 
DNA was performed as described previously (Schnell-
mann et al., 2006). Digested DNA was separated by 
gel electrophoresis in a contour-clamped homogeneous 
electric field DRIII device (Bio-Rad Laboratories Inc., 
Richmond, CA) with a ramped pulse time of 5 to 40 s 
at 6 V/cm for 21 h at 12°C. The lambda ladder PFG 
marker (New England BioLabs) was used as a size 
reference. The digital PFGE pattern images were ana-
lyzed with the BioNumerics software (Applied Maths, 
Kortrijk, Belgium), and the PFGE profiles were defined 
by the DNA banding patterns and criteria of Tenover 
et al. (1995).
Multilocus Sequence Typing
All Staph. epidermidis isolates (n = 15) were exam-
ined by multilocus sequence typing (MLST), which 
is based on the sequencing of internal fragments of 7 
housekeeping genes (Thomas et al., 2007). Allele and 
sequence type (ST) numbers were assigned according 
to the Staph. epidermidis MLST database (http://sepi-
dermidis.mlst.net/).
Detection of ica and ACME
The Staph. epidermidis isolates (n = 15) were tested 
by PCR for the biofilm operon ica (Gu et al., 2005) and 
ACME. The presence and type of ACME was deter-
mined using the primer pairs AIPS.27 and AIPS.28 for 
arcA and AIPS.45 and AIPS.46 for opp3 gene clusters 
(Diep et al., 2008).
Statistical Analysis 
Antimicrobial resistance phenotypes (Table 2) were 
compared using the Fisher exact test. This test is useful 
when the sample size is small (zero in some cells), and 
the test evaluates the hypothesis that the 2 column 
percentages in a 2 × 2 table are equal. Statistical analy-
sis was performed with the statistical software NCSS 
2007 (www.ncss.com). The overall level of statistical 
significance was set to P < 0.05.
RESULTS
Prevalence and Identification of CNS
In total, 97.8% of the CNS isolates (n = 408) were 
clearly identified at the species level by MALDI-TOF 
MS analysis. The most frequent CNS species were 
Staph. xylosus, Staph. chromogenes, Staph. sciuri, and 
Staph. haemolyticus (Table 3). The remaining 2.2% 
were identified by 16S rDNA analysis as Staph. chro-
mogenes (n = 1), Staph. saprophyticus (n = 1), or novel 
Staphylococcus species (n = 7; Table 3). Neither clinical 
nor subclinical mastitis could be correlated with the 
presence of individual bacterial species. Similar species 
were identified in control milk samples with low SCC. Of 
the 417 CNS, 268 isolates were the only species present 
in the milk from which they originated, and 149 isolates 
were present together with at least one other species. 
Staphylococcus xylosus (n = 92), Staph. chromogenes 
(n = 56), Staph. haemolyticus (n = 22), and Staph. 
sciuri (n = 21) were the predominant species among 
the 268 isolates that had only a single CNS species 
present (Table 4). Among the mixed cultures, 18 CNS 
isolates were co-purified with Staph. aureus (12.1%), 83 
isolates were present with Streptococcus spp. (55.7%), 
and 48 isolates (32.2%) were coincident in milk with at 
least one other bacterium (e.g., Trueperella pyogenes, 
Escherichia coli, Corynebacterium bovis, or a mix of 
more than 3 different bacteria; Table 4). In the milk 
samples, none of the CNS was found more frequently as 
a single agent than together with other bacteria, with 
the exception of Staph. chromogenes, which was not 
often found together with Staph. aureus or streptococci 
(Table 4).
Analysis of Antimicrobial Resistance  
Phenotypes and Genotypes
Oxacillin resistance, which is the indicator of mec 
gene-mediated methicillin resistance, was the most fre-
quent resistance phenotype (47.0% of isolates), followed 
by resistance to fusidic acid (34.1%), tiamulin (31.9%), 
penicillin (23.3%), tetracycline (15.8%), streptomycin 
(9.6%), and erythromycin (7.0%; Table 2). Resistance 
to 2 or more antibiotics was observed in 15.1% of the 
CNS isolates. Multidrug-resistant isolates were found 
in milk from clinical (n = 21) and subclinical (n = 34) 
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mastitis cases and in control milk (n = 8). Oxacillin 
resistance was significantly more frequent in clinical 
mastitis isolates (56.5%) than in subclinical mastitis 
isolates (43.9%), whereas sulfamethoxazole resistance 
was significantly more frequent in clinical mastitis 
isolates (11.3%) than in control milk. No significant 
Table 3. Prevalence of CNS and distribution of different CNS strains in clinical and subclinical mastitis milk and control milk 
CNS
Total Clinical mastitis milk
Subclinical mastitis 
milk Control milk1
No. % No. % No. % No. %
Total strains 417 100.0  115 100.0  255 100.0  47 100.0
Staphylococcus xylosus 150 36.0  43 37.4  95 37.2  12 25.5
Staphylococcus chromogenes 70 16.8  20 17.4  40 15.7  10 21.3
Staphylococcus sciuri 37 8.9  10 8.7  25 9.8  2 4.3
Staphylococcus haemolyticus 35 8.4  8 6.9  23 9.0  4 8.5
Staphylococcus devriesei 18 4.3  7 6.0  11 4.3  0 0.0
Staphylococcus warneri 17 4.1  4 3.5  6 2.3  7 14.8
Staphylococcus simulans 16 3.8  1 0.9  13 5.1  2 4.3
Staphylococcus epidermidis 15 3.6  4 3.5  10 3.9  1 2.1
Staphylococcus fleurettii 12 2.9  6 5.2  4 1.6  2 4.3
Staphylococcus succinus 9 2.2  0 0.0  7 2.8  2 4.3
Staphylococcus vitulinus 9 2.2  5 4.4  4 1.6  0 0.0
Staphylococcus hyicus 6 1.4  2 1.7  4 1.6  0 0.0
Staphylococcus equorum 6 1.4  1 0.9  2 0.8  3 6.3
Staphylococcus saprophyticus 2 0.5  1 0.9  1 0.4  0 0.0
Staphylococcus auricularis 2 0.5  1 0.9  1 0.4  0 0.0
Staphylococcus capitis 2 0.5  0 0.0  2 0.8  0 0.0
Staphylococcus cohnii 2 0.5  0 0.0  0 0.0  2 4.3
Staphylococcus hominis 1 0.2  0 0.0  1 0.4  0 0.0
Staphylococcus lentus 1 0.2  0 0.0  1 0.4  0 0.0
Staphylococcus spp. 7 1.6  2 1.7  5 1.9  0 0.0
1Milk taken from cows after mastitis treatment.
Table 4. Distribution of CNS as single agent and associated with other pathogens in the milk samples 
CNS
Proportion of CNS (n = 417)
Total 
(n = 417)
Occurring as a  
single agent 
(n = 268)
Occurring in a mixed culture (n = 149)
With Staph.  
aureus (n = 18)
With  
Streptococcus spp.  
(n = 83)
With other  
bacteria1 
(n = 48)
No. No. % No. % No. % No. %
Staphylococcus xylosus 150  92 34.3  7 38.9 34 41.0 17 35.4
Staphylococcus chromogenes 70  56 20.9  1 5.6 5 6.0 8 16.7
Staphylococcus sciuri 37  21 7.8  1 5.6 10 12.0 5 10.4
Staphylococcus haemolyticus 35  22 8.2  0 0.0 9 10.8 4 8.3
Staphylococcus devriesei 18  13 4.9  0 0.0 3 3.6 2 4.2
Staphylococcus warneri 17  11 4.1  1 5.6 3 3.6 2 4.2
Staphylococcus simulans 16  14 5.2  0 0.0 2 2.4 0 0.0
Staphylococcus epidermidis 15  10 3.7  2 11.1 2 2.4 1 2.1
Staphylococcus fleurettii 12  4 1.5  1 5.6 4 4.8 3 6.3
Staphylococcus succinus 9  5 1.9  2 11.1 2 2.4 0 0.0
Staphylococcus vitulinus 9  2 0.7  3 16.7 0 0.0 4 8.3
Staphylococcus hyicus 6  2 0.7  0 0.0 3 3.6 1 2.1
Staphylococcus equorum 6  5 1.9  0 0.0 1 1.2 0 0.0
Staphylococcus saprophyticus 2  0 0.0  0 0.0 2 2.4 0 0.0
Staphylococcus auricularis 2  1 0.4  0 0.0 1 1.2 0 0.0
Staphylococcus capitis 2  2 0.7  0 0.0 0 0.0 0 0.0
Staphylococcus cohnii 2  2 0.7  0 0.0 0 0.0 0 0.0
Staphylococcus hominis 1  0 0.0  0 0.0 1 1.2 0 0.0
Staphylococcus lentus 1  1 0.4  0 0.0 0 0.0 0 0.0
Staphylococcus spp. 7  5 1.9  0 0.0 1 1.2 1 2.1
1Indicates at least one species other than Staphylococcus aureus and Streptococcus spp. (e.g., Trueperella pyogenes, Escherichia coli, Corynebacterium 
bovis) or a mix of more than 3 different bacteria.
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difference in resistance between isolates was observed 
for the other antimicrobials tested (Table 2). 
Oxacillin resistance was attributed to the mecA gene 
present in 9.7% (n = 19) of the oxacillin-resistant iso-
lates (n = 196). The mecA gene was detected in Staph. 
fleurettii (11/12), Staph. epidermidis (6/15), Staph. hae-
molyticus (1/37), and Staph. xylosus (1/155) isolates. 
The mecA or mecC gene was not detected in the other 
177 oxacillin-resistant isolates (90.3%; Table 5). These 
isolates exhibited an oxacillin MIC of 0.5 or 1.0 μg/mL, 
which is just above the clinical resistance breakpoint. 
Twenty of these 177 oxacillin-resistant mecA- and 
mecC-negative isolates contained a blaZ gene express-
ing a β-lactamase. The remaining isolates were also 
negative for blaZ (Table 5). Among them, all Staph. 
sciuri isolates (n = 37) contained the mecA1 gene, and 
exhibited low-level resistance to oxacillin (MIC between 
0.5 and 1.0 μg/mL). The low oxacillin resistance was 
due to the absence of the T→A mutation in the −10 
promoter sequence (Wu et al., 2001), as demonstrated 
by PsiI restriction analysis.
Resistance to other antimicrobials correlated with 
the presence of the associated resistance genes (Table 
5): the β-lactamase gene blaZ; the tetracycline efflux 
genes tet(L) and tet(K); the streptomycin adenyltrans-
ferase and nucleotidyltransferase genes ant(6)-Ia and 
str; the chloramphenicol acetyltransferase genes catpC221 
and catpC223; the gentamicin acetyltransferase gene 
aac(6’)-Ie; the kanamycin-neomycin phosphotrans-
ferase genes aph(2’)-Ia and aph(3c)-III; the macrolide 
and lincosamide 23S rRNA methylase genes erm(B) 
and erm(C); the macrolide efflux gene msr; the lin-
cosamide nucleotidyltransferase gene lnu(A); and the 
trimethoprim-resistant dihydrofolate reductase genes 
dfr(A), dfr(D), dfr(G), and dfr(K). In a few strains, 
resistance to erythromycin, clindamycin, streptomycin, 
gentamicin, chloramphenicol, and trimethoprim could 
not be explained by the presence of any of the tested 
genes, suggesting new antimicrobial resistance mecha-
nisms in CNS (Table 5).
Resistance to fusidic acid was not due to the known 
fusidic acid resistance genes fus(B), and fus(C), sug-
gesting the appearance of new resistance genes or mu-
tations in the elongation factor G fus(A) (Farrell et al., 
2011). Similarly, no known tiamulin resistance genes 
(vga or lsa) were detected in the tiamulin-resistant 
strains. Resistance to sulfonamides was not further 
characterized.
Multiple combinations of these genes were found in 
4.8% of the CNS isolates. The most frequent resistance 
genes detected in combination were those conferring 
resistance to oxacillin, tetracycline, penicillin, strep-
tomycin, gentamicin, kanamycin, erythromycin, and 
clindamycin (Table 6). The presence of several genes 
in one isolate was linked to the presence of mecA in 
Staph. epidermidis (n = 6), Staph. sciuri (n = 3), Staph. 
haemolyticus (n = 1), and Staph. fleurettii (n = 1). The 
other mecA positive isolates [Staph. fleurettii (n = 10) 
and Staph. xylosus (n = 1)] contained only the mecA 
gene. The CNS isolates lacking mecA, but containing 
several other resistance genes were classified as Staph. 
chromogenes (n = 3), Staph. epidermidis (n = 3), Staph. 
haemolyticus (n = 1), and Staph. warneri (n = 2; Table 
6). All CNS isolates containing several resistance genes 
were found in milk samples from cows presenting with 
subclinical or clinical mastitis (Table 6). Although one 
Staph. xylosus isolate contained a mecA gene, multidrug 
resistance was never observed in Staph. xylosus, the 
most frequently detected CNS in our study.
Genotyping of Methicillin-Resistant CNS
The CNS strains containing the mecA gene (n = 19) 
were further analyzed for mecA sequences, clonality, 
and SCCmec and ACME types. Two different mecA 
genes with slight sequence differences were detected in 
Staph. epidermidis isolates (Figure 1). Four mecA genes 
that slightly differed from each other were found in 
Staph. fleurettii (Figure 1). The mecA genes detected 
in Staph. haemolyticus and Staph. xylosus also differed 
slightly from each other and from those in Staph. epi-
dermidis and Staph. fleurettii (Figure 1). 
Analysis of methicillin-resistant Staph. epidermidis (n 
= 6) and Staph. fleurettii (n = 11) by PFGE showed 
that strains of the same species were not clonally 
related, except for 4 Staph. fleurettii from 4 different 
farms that showed 2 similar PFGE patterns (Figure 
1). Methicillin-resistant Staph. epidermidis belonged to 
ST59 (n = 2), ST55, ST89, and the new strains ST452 
and ST454, whereas Staph. epidermidis strains lacking 
the mecA gene (methicillin-sensitive Staph. epidermidis, 
MSSE) and displaying a multidrug-resistance profile 
belonged to ST111 (n = 4), ST184 (n = 1), ST293 (n 
= 1), and to the new strain ST453 (n = 1); MSSE also 
showed a different PFGE profile (data not shown).
Several different SCCmec elements were detected 
among the methicillin-resistant CNS isolates (Figure 1). 
Staphylococcus epidermidis strains contained SCCmec 
IV (n = 4), SCCmec V (n = 1), and one nontypeable 
SCCmec related to types IV and VI. Staphylococcus 
haemolyticus (n = 1) and Staph. xylosus (n = 1) both 
contained a nontypeable SCCmec. The mecA gene of 
Staph. fleurettii strains (n = 11) were associated with 
the class A mec gene complex and could not be as-
signed to a known SCCmec element (Figure 1). Two 
methicillin-resistant Staph. epidermidis strains, ST59-
SCCmec IV and ST454-SCCmec V, contained a type 
2 and type 3 ACME, respectively; ACME type 1 was 
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Table 5. Distribution of antimicrobial resistance and antimicrobial resistance genes in CNS from bovine milk 
Antimicrobial  
substance
Phenotypic 
resistance (%) Resistance genes1
Resistance genes  
in resistant isolates
Species (no.)No. %
Oxacillin2 47.0 mecA 19 9.7 Staph. fleurettii (11), Staph. epidermidis (6), Staph. haemolyticus (1), Staph. xylosus (1)
mecA1 37 18.9 Staph. sciuri (37)
No mecA/A1/C; blaZ 20 10.2 Staph. chromogenes (9), Staph. xylosus (5), Staph. cohnii (2), Staph. saprophyticus (2), 
Staph. warneri (2)
No mecA/A1/C; no blaZ 120 61.2 Staph. xylosus (97), Staph. vitulinus (8), Staph. succinus (5), Staph. chromogenes (2), 
Staph. devriesei (1), Staph. equorum (1), Staph. hyicus (1), Staph. lentus (1), Staph. 
simulans (1), Staph. warneri (1), Staphylococcus spp. (2)
Penicillin3 23.3 blaZ 88 90.7 Staph. chromogenes (37), Staph. devriesei (11), Staph. haemolyticus (11), Staph. xylosus 
(9), Staph. epidermidis (9), Staph. warneri (3), Staph. cohnii (2), Staph. saprophyticus 
(2), Staph. auricularis (1), Staph. capitis (1), Staph. fleurettii (1), Staph. hominis (1)
No β-lactamase4 8 8.3 Staph. fleurettii (8)
Unknown 1 1.0 Staph. xylosus (1)
Tetracycline 15.8 tet(K) 62 95.4 Staph. xylosus (33), Staph. warneri (7), Staph. epidermidis (6), Staph. sciuri (4), Staph. 
chromogenes (3), Staph. simulans (3), Staph. fleurettii (2), Staph. vitulinus (2), Staph. 
haemolyticus (1), Staphylococcus sp. (1)
tet(L) 3 4.6 Staph. chromogenes (3)
Streptomycin 9.6 str 36 90.0 Staph. chromogenes (12), Staph. epidermidis (7), Staph. sciuri (5), Staph. haemolyticus 
(4), Staph. devriesei (3), Staph. warneri (2), Staph. simulans (1), Staph. vitulinus (1), 
Staph. fleurettii (1)
ant(6)-Ia 3 7.5 Staph. epidermidis (2), Staph. haemolyticus (1)
Unknown 1 2.5 Staph. haemolyticus (1)
Erythromycin 7.0 erm(B) 2 7.4 Staph. chromogenes (1), S fleurettii (1)
erm(C) 11 40.8 Staph. epidermidis (6), Staph. haemolyticus (4), Staph. warneri (1)
msr 6 22.2 Staph. xylosus (3), Staph. epidermidis (2), Staph. hominis (1)
Unknown 8 29.6 Staph. equorum (3), Staph. xylosus (1), Staph. cohnii (1), Staph. fleurettii (1), Staph. 
spp. (2)
Clindamycin 3.4 erm(B) 2 14.3 Staph. chromogenes (1), Staph. sciuri (1)
erm(C) 8 57.2 Staph. haemolyticus (4), Staph. epidermidis (4)
lnu(A) 1 7.1 Staph. xylosus (1)
Unknown 3 21.4 Staph. xylosus (1), Staph. fleurettii (1), Staph. lentus (1)
Chloramphenicol 3.1 catpC221 7 53.8 Staph. epidermidis (3), Staph. xylosus (2), Staph. chromogenes (1), Staph. sciuri (1)
catpC223 4 30.8 Staph. cohnii (1), Staph. haemolyticus (1), Staph. simulans (1), Staph. xylosus (1)
Unknown 2 15.4 Staph. haemolyticus (1), Staph. simulans (1)
Kanamycin 2.4 aac(6’)-Ie–aph(2’)-Ia 7 70.0 Staph. epidermidis (4), Staph. sciuri (1), Staph. chromogenes (1), Staph. fleurettii (1)
aph(3c)-III 3 30.0 Staph. haemolyticus (2), Staph. epidermidis (1)
Gentamicin 2.4 aac(6’)-Ie–aph(2’)-Ia 7 70.0 Staph. epidermidis (4), Staph. sciuri (1), Staph. chromogenes (1), Staph. fleurettii (1)
Unknown 3 30.0 Staph. haemolyticus (2), Staph. xylosus (1)
Trimethoprim 1.2 dfr(A) 1 20.0 Staph. epidermidis (1)
dfr(D) 2 40.0 Staph. sciuri (1), Staph. fleurettii (1)
dfr(G) 1 20.0 Staph. vitulinus (1)
dfr(K) 1 20.0 Staph. chromogenes (1)
1Antimicrobial resistance genes and their functions: mecA and mecA1 = penicillin-binding proteins; blaZ = β-lactamase; tet(K) and tet(L) = tetracycline efflux proteins; str = 
streptomycin nucleotidyltransferase; ant(6)-Ia = streptomycin adenyltransferase; erm(B) and erm(C) = macrolide, lincosamide, and streptogramin B 23S rRNA methylase; msr = 
macrolide efflux gene; lnu(A) = lincosamide nucleotidyltransferase; catpC221 and catpC223 = chloramphenicol acetyltransferases; aac(6’)-Ie–aph(2’)-Ia = gentamicin, kanamycin, and 
neomycin acetyltransferase; aph(3c)-III = kanamycin and neomycin phosphotransferase; dfr(A), dfr(D), dfr(G),dfr(K) = trimethoprim-resistant dihydrofolate reductases.
2Oxacillin, indicator antimicrobial for the presence of an alternative penicillin-binding protein (PBP 2a) encoded by mec genes.
3Penicillin used for the prediction of a β-lactamase.
4Does not produce β-lactamase, but contained mecA.
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Table 6. Occurrence of multiple antimicrobial resistance genes in CNS isolated from the milk of 20 different cows suffering from bovine mastitis 
Isolate CNS species Mastitis Resistance1,2
mecA positive    
 M1529/10 Staph. epidermidis Subclinical erm(C): CLI, ERY; tet(K): TET; str: STR; blaZ: PEN; aac(6’)-Ie–aph(2’)-Ia: GEN-KAN; dfr(A): TMP; mecA: OXA
 M1186/10 Staph. epidermidis Clinical erm(C): CLI, ERY; tet(K): TET; ant(6)-Ia: STR; blaZ: PEN; aac(6’)-Ie–aph(2’)-Ia: GEN-KAN; mecA: OXA
 M4460/09 Staph. fleurettii Clinical erm(B): CLI, ERY; str: STR; blaZ: PEN; aac(6’)-Ie–aph(2’)-Ia: GEN-KAN; dfr(D): TMP; mecA: OXA
 M1570/10 Staph. haemolyticus Clinical erm(C): CLI, ERY; tet(K): TET; blaZ: PEN; aph(3c)-III: KAN; mecA: OXA
 M744/10 Staph. epidermidis Subclinical str: STR; catpC221: CHL; aac(6’)-Ie–aph(2’)-Ia: GEN-KAN; erm(C): CLI. ERY; mecA: OXA
 M1383/10 Staph. epidermidis Subclinical erm(C): CLI, ERY; blaZ: PEN; aac(6’)-Ie–aph(2’)-Ia: GEN-KAN; mecA: OXA
 M1965/10 Staph. sciuri Clinical tet(K): TET; str: STR; aac(6’)-Ie–aph(2’)-Ia: GEN-KAN; dfr(D): TMP; mecA1: OXA
 M8/10 Staph. epidermidis Clinical ant(6)-Ia: STR; blaZ: PEN; catpC221: CHL; aph(3c)-III: KAN; erm(C): CLI, ERY; mecA: OXA
 M1201/10 Staph. sciuri Subclinical tet(K): TET; str: STR; catpC221: CHL; mecA1: OXA
 M703/10 Staph. epidermidis Subclinical blaZ: PEN; msr: ERY; mecA: OXA
 M3901/09 Staph. sciuri Clinical tet(K): TET; str: STR; mecA1: OXA
mecA negative    
 M425/10 Staph. chromogenes Subclinical erm(B): CLI, ERY; tet(L): TET; blaZ: PEN; catpC221: CHL; dfr(K): TMP
 M47/10 Staph. chromogenes Subclinical tet(L): TET; str: STR; blaZ: PEN; aac(6’)-Ie–aph(2’)-Ia: GEN-KAN
 M1256/10 Staph. warneri Subclinical str: STR; blaZ: PEN; erm(C): CLI, ERY
 M4233–1/09 Staph. epidermidis Subclinical erm(C): CLI-ERY; tet(K): TET; str: STR
 M4298–1/09 Staph. epidermidis Subclinical tet(K): TET; str: STR; blaZ: PEN; catpC221: CHL
 M46/10 Staph. chromogenes Subclinical tet(K): TET; str: STR; blaZ: PEN
 M523/10 Staph. epidermidis Clinical tet(K): TET; str: STR; blaZ: PEN
 M619–2/10 Staph. haemolyticus Subclinical ant(6)-Ia: STR; blaZ: PEN; aph(3c)-III: KAN
 M1094–1/10 Staph. warneri Subclinical tet(K): TET; str: STR; blaZ, PEN
1Antimicrobial resistance genes and their functions: erm(B) and erm(C) = macrolide, lincosamide, and streptogramin B 23S rRNA methylase; tet(K) and tet(L) = tetracycline 
efflux proteins; str = streptomycin nucleotidyltransferase; blaZ = β-lactamase; aac(6’)-Ie–aph(2’)-Ia = gentamicin, kanamycin, and neomycin acetyltransferase; dfr(A), dfr(D), 
dfr(G),dfr(K) = trimethoprim-resistant dihydrofolate reductases; mecA and mecA1 = penicillin-binding proteins; ant(6)-Ia = streptomycin adenyltransferase; aph(3c)-III = kana-
mycin and neomycin phosphotransferase; catpC221 and catpC223 = chloramphenicol acetyltransferases; msr = macrolide efflux gene. 
2Antibiotics: CLI = clindamycin; TET = tetracycline; STR = streptomycin; PEN = penicillin; KAN = kanamycin; GEN = gentamicin; TMP = trimethoprim; ERY = erythromycin; 
OXA = oxacillin; CHL = chloramphenicol.
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detected in 4 MSSE ST111 and in 1 MSSE ST456. 
None of the Staph. epidermidis isolates carried the 
biofilm-formation operon ica (Figure 1).
DISCUSSION
Many diverse CNS species have been identified in bo-
vine milk, and MALDI-TOF MS is a reliable and rapid 
method to identify CNS species (Loonen et al., 2012). 
We observed that a short ethanol-formic acid extrac-
tion is necessary for accurate identification. The CNS 
in milk were frequently detected as single bacterial spe-
cies, suggesting that these species were the infectious 
agents. However, the presence of these CNS species was 
not correlated with a clinical mastitis diagnosis (Table 
3). The most frequently occurring species in this study 
were Staph. xylosus, Staph. chromogenes, Staph. sciuri, 
and Staph. haemolyticus, as reported in other studies 
(Piessens et al., 2011; Supré et al., 2011; Waller et al., 
2011). Although Staph. xylosus is not known to cause 
mastitis, it was detected in 35.9% of the milk samples 
in our study and as a single species in 22.8% of those 
samples, emphasizing previous conclusions that Staph. 
xylosus is an underestimated pathogenic CNS in bovine 
mastitis (Supré et al., 2011). Additionally, two-thirds 
of the Staph. xylosus isolates were resistant to oxacillin 
but lacked a known mec gene. The absence of a mecA 
gene was also observed in other oxacillin-resistant CNS 
isolates (Table 5). The presence of a blaZ overexpress-
ing β-lactamase may explain decreased susceptibility to 
oxacillin in some of the strains, as has been described in 
borderline oxacillin-resistant Staph. aureus (McDougal 
and Thornsberry, 1986). For the other oxacillin-resis-
tant isolates lacking mec and blaZ genes, independent 
mechanisms (which may not be related to an acquired 
resistance gene) explain the decreased susceptibility to 
oxacillin with MIC in the range of 0.5 to 2.0 μg/mL. 
Oxacillin resistance in Staph. sciuri may also depend on 
mecA1 gene overexpression. Alterations to the promoter 
region of mecA1 are necessary for high-level mecA1 ex-
pression and oxacillin resistance in Staph. sciuri (Wu et 
al., 2001, 2005; Couto et al., 2003). In our study, none 
of the Staph. sciuri strains contained the −10 promoter 
mutation that is associated with oxacillin resistance 
(Wu et al., 2001). However, the MIC for these isolates 
were between 0.5 and 1.0 μg/mL, values that are above 
Figure 1. Genetic background and properties of methicillin-resistant CNS from bovine mastitis milk from Switzerland. The phylogenetic tree 
was constructed from pulsed-field gel electrophoresis (PFGE) patterns of 19 methicillin-resistant CNS isolates. Cluster analysis was generated 
by Bionumerics 6.6 (Applied Maths, Kortijk, Belgium). The dotted line indicates the cut-off value of ≥90% determining clonality between the 
isolates, according to the criteria of Tenover et al. (1995). (a) mecA of Staphylococcus haemolyticus M1570/10 (EMBL accession no. HE978799); 
(b) mecA identical to mecA of Staphylococcus epidermidis RP26A (EMBL accession no. CP000029); (c) mecA of Staph. epidermidis M8/10 
(EMBL accession no. HE978797); (d) mecA of Staph. epidermidis M703/10 (EMBL accession no. HE978798); (e) mecA identical to mecA of 
Staphylococcus fleurettii M143/10 (EMBL accession no. HE978795); (f) mecA of Staph. fleurettii M3783/09 (EMBL accession no. HE978796); (g) 
mecA of Staph. fleurettii M205/10 (EMBL accession no. HE978794); (h) mecA of Staph. fleurettii M4460/09 (EMBL accession no. HE861945); 
(i) mecA of Staphylococcus xylosus M1545/10 (EMBL accession no. HE978800); (j) mecA of Staph. fleurettii has been reported to be chromosom-
ally encoded and only contains part of the class A mec gene complex; it is not associated with a staphylococcal cassette chromosome (SCCmec) 
element (Tsubakishita et al., 2010). NT = not typeable.
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the CLSI and EUCAST resistance breakpoints. The 
clinical and therapeutic relevance of decreased suscep-
tibility to oxacillin remains to be clarified. The oxacillin 
breakpoint may be set low to properly gauge resistance 
in CNS from bovine mastitis cases (Fessler et al., 2010), 
and detection of acquired mec genes may be necessary 
for correct interpretation of the antibiogram. 
The mecA gene was detected in Staph. epidermidis, 
Staph. fleurettii, Staph. haemolyticus, and Staph. xylo-
sus. Three mecA genes that differed from each other in 
only a few base pairs were found in the methicillin-re-
sistant Staph. fleurettii and Staph. epidermidis isolates, 
suggesting the independent acquisition of the mecA 
gene in these species. This conclusion is supported by 
the observation that the different SCCmec elements 
were detected in individual Staph. epidermidis isolates, 
and that all but one Staph. fleurettii isolate contained a 
mecA gene associated with the class A mec gene com-
plex. It has been reported that the mecA-containing re-
gion in Staph. fleurettii is not associated with a SCCmec 
element but is encoded chromosomally within a part 
of the class A mec gene complex (Tsubakishita et al., 
2010). It is therefore expected that the Kondo typing 
method (Kondo et al., 2007) detects the chromosomal 
class A mec gene complex in Staph. fleurettii. Genetic 
diversity was confirmed by PFGE, which showed that, 
except for 2 pairs of Staph. fleurettii with similar PFGE 
profiles, all methicillin-resistant CNS isolates had dif-
ferent PFGE profiles. Despite different PFGE profiles, 
Staph. epidermidis isolates belonging to the ST111 and 
ST59 groups were predominant in bovine mastitis cases, 
suggesting that a specific clonal lineage of Staph. epi-
dermidis has adapted to the udder environment (Pies-
sens et al., 2012). Half of the Staph. epidermidis isolates 
contained an ACME operon, which may be involved in 
host adaptation in humans (Miragaia et al., 2009). The 
ACME were mainly observed in the Staph. epidermidis 
ST59 or ST111 groups, suggesting that it may also play 
a role in host adaptation in cows. Additionally, Staph. 
epidermidis was the predominant CNS species among 
those that contained multiple antimicrobial resistance 
genes. Multiple resistance genes were also found in 
Staph. sciuri, Staph. chromogenes, Staph. haemolyticus, 
and Staph. fleurettii, and these genes were frequently 
associated with the presence of the mecA gene. Genes 
conferring resistance to clinically relevant antimicrobi-
als such as the penicillins, macrolides, lincosamides, 
and aminoglycosides were also detected. In total, 15.1% 
of the isolates studied were resistant to more than 2 an-
timicrobials, and some strains were virtually resistant 
to all antimicrobials authorized for the treatment of 
mastitis. The remaining CNS isolates were susceptible 
to antimicrobials commonly used in mastitis treatment.
Our study demonstrated that CNS species in milk 
from cows experiencing mastitis are generally suscepti-
ble to the antimicrobials commonly used for treatment. 
However, CNS have the potential to acquire resistance 
genes, leading to therapeutic failures. Some multidrug-
resistant isolates, especially Staph. epidermidis, Staph. 
chromogenes, and Staph. haemolyticus, are present 
in bovine mastitis milk and may resist antimicrobial 
treatment. An antibiogram is therefore recommended 
for targeted therapy, and chronically infected cows 
should be culled from the herd.
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